Anika Therapeutics Inc.

NASDAQ: ANIK · Real-Time Price · USD
8.82
0.18 (2.08%)
At close: Aug 15, 2025, 3:40 PM

Anika Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
91.85M 105.55M 119.91M 164.17M 166.88M 169.26M 166.66M 163.31M 162.11M 157.47M 156.24M 152.44M 151.71M 150.19M 147.79M 144.66M 136.82M 129.35M
Cost of Revenue
38.8M 39.5M 43.91M 84.41M 63.61M 64.39M 63.57M 62.42M 63.39M 62.85M 62.66M 64.86M 63.88M 66.42M 64.85M 63.11M 60.95M 60.55M
Gross Profit
53.05M 66.05M 76M 79.76M 103.27M 104.87M 103.09M 100.89M 98.72M 94.61M 93.58M 87.58M 87.82M 83.77M 82.94M 81.55M 75.87M 68.8M
Operating Income
-8.66M -4.32M -5.1M -34.51M -14.17M -17.96M -25.45M -30.52M -28.65M -28.4M -19.4M -21.86M -14.76M -2.2M 2.62M -6.21M -15.44M -34.16M
Interest Income
406K 406K 406K 983K 1.21M 1.77M 1.77M 1.47M 1.27M 712K 712K 436K n/a n/a n/a 116K 188K 219K
Pretax Income
-6.88M -2.16M -2.76M -94.53M -73.96M -77.78M -85.33M -28.51M -26.84M -27.05M -18.75M -21.52M -14.91M -2.5M 2.43M -6.54M -15.95M -34.78M
Net Income
-60.63M -56.74M -56.38M -97.52M -74.18M -76.83M -82.67M -24.57M -22.17M -22.28M -14.86M -15.74M -11.01M -1.64M 4.13M -5.73M -12.7M -26.94M
Selling & General & Admin
39.36M 46.93M 55.55M 80.78M 86.5M 90.38M 95.85M 98.56M 95.01M 92.59M 84.79M 82.18M 78.4M 75.12M 74.1M 68.84M 67.25M 63.81M
Research & Development
22.35M 23.44M 25.54M 30.39M 30.94M 32.45M 32.69M 32.85M 32.36M 30.43M 28.18M 26.43M 26.8M 27.12M 27.33M 28.96M 26.5M 23.74M
Other Expenses
n/a n/a n/a 3.1M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
61.71M 70.37M 81.1M 114.27M 117.43M 122.83M 128.54M 131.41M 127.37M 123.01M 112.98M 108.61M 105.21M 102.25M 101.42M 97.8M 93.75M 87.55M
Interest Expense
629K n/a 592K 592K 592K 1.15M 561K 837K 1.27M 808K 808K 532K 96K n/a n/a 300K 600K 800K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
98.31M 107.67M 122.81M 198.68M 181.05M 187.22M 192.11M 193.84M 190.76M 185.87M 175.64M 173.47M 169.09M 168.67M 166.27M 160.91M 154.69M 148.1M
Income Tax Expense
5.95M 6.11M 6.06M 2.99M 220K -953K -2.66M -3.94M -4.66M -4.78M -3.89M -5.78M -3.9M -859K -1.71M -810K -3.25M -7.84M
Shares Outstanding (Basic)
14.33M 14.3M 14.58M 14.77M 14.84M 14.7M 14.65M 14.63M 14.69M 14.58M 14.64M 14.4M 14.21M 14.47M 14.37M 14.43M 14.39M 14.34M
Shares Outstanding (Diluted)
14.33M 14.3M 14.72M 14.77M 14.84M 14.7M 14.65M 14.63M 14.69M 14.65M 14.64M 14.6M 14.55M 14.47M 14.44M 14.65M 14.63M 14.44M
EPS (Basic)
-4.15 -3.88 -3.85 -6.65 -5.07 -5.25 -5.65 -1.69 -1.53 -1.54 -1.03 -1.09 -0.76 -0.11 0.29 -0.41 -0.9 -1.89
EPS (Diluted)
-4.15 -3.88 -3.85 -6.65 -5.07 -5.25 -5.65 -1.69 -1.53 -1.54 -1.03 -1.09 -0.76 -0.11 0.29 -0.41 -0.9 -1.89
EBITDA
-5.84M 633K 1.45M -23.09M -1.8M -4.1M -11.23M -16.22M -14.39M -13.98M -4.91M -6.48M 1.07M -229K 966K 2.97M -2.55M -3.22M
EBIT
-7.18M -6.42M -6.61M -94.53M -74.59M -78.98M -87.06M -30.52M -28.65M -28.4M -19.4M -21.9M -14.85M -2.34M -2.35M -11.02M -16.05M -34.68M
Depreciation & Amortization
3.62M 7.27M 8.28M 10.44M 12.29M 14.38M 15.33M 15.99M 15.92M 13.93M 12.46M 12.3M 12.32M 14.17M 16M 15.41M 14.93M 14.62M